# Clopidogrel for Acute Ischaemia of Recent Onset

Study · id `cardio:ct-nct02776540` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02776540](<https://clinicaltrials.gov/study/NCT02776540>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02776540

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.

## Technical summary

Registry record NCT02776540. Randomized; triple masking; primary purpose treatment. Start 2016-06-01 (actual); primary completion 2019-02-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 188 participants (enrolled count; ClinicalTrials.gov record NCT02776540, source copy `cardio:ctgov-nct02776540-2019-02-12`, retrieved 2026-10-26)
- Started: 2016-06-01 (actual) (ClinicalTrials.gov record NCT02776540, source copy `cardio:ctgov-nct02776540-2019-02-12`, retrieved 2026-10-26)
- Primary completion: 2019-02-01 (actual) (ClinicalTrials.gov record NCT02776540, source copy `cardio:ctgov-nct02776540-2019-02-12`, retrieved 2026-10-26)
- Completion: 2019-02-01 (actual) (ClinicalTrials.gov record NCT02776540, source copy `cardio:ctgov-nct02776540-2019-02-12`, retrieved 2026-10-26)
- Countries: Egypt (ClinicalTrials.gov record NCT02776540, source copy `cardio:ctgov-nct02776540-2019-02-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02776540-2019-02-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clopidogrel for Acute Ischaemia of Recent Onset
- Acronym: CAIRO
- Condition: Ischemic Cerebrovascular Accident
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Aspirin
- Lead sponsor: Ain Shams University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Ain Shams University (`cardio:org-ain-shams-university`)

## Provenance

Content hash: 3fd76ee65348e6e828265f5255d20aa54032d407e0480fe90c042225c77bd096
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
